Health and Fitness Health and Fitness
Tue, October 19, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
MannKind Announces Initiation of Phase 2 Trial of Cancer Vaccine for Advanced Melanoma
[ Tue, Oct 19th 2010 ] - Market Wire
USANA Schedules Third Quarter Earnings Release and Conference Call
[ Tue, Oct 19th 2010 ] - Market Wire
Vitro Expands HemoGenix Alliance to Include Cell-based Testing for Liver Toxicity
[ Tue, Oct 19th 2010 ] - Market Wire
Fonds de solidarite FTQ Converting Remainder of its Preferred Shares in Bioniche
[ Tue, Oct 19th 2010 ] - Market Wire
Greatbatch, Inc. to Host Third Quarter 2010 Earnings Conference Call on Thursday, October 28, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
Seattle Genetics to Host Conference Call and Webc .. uarter 2010 Financial Results on November 1, 2010
[ Tue, Oct 19th 2010 ] - Market Wire
AtriCure to Announce Third Quarter 2010 Financial Results
[ Tue, Oct 19th 2010 ] - Market Wire
MabCure Signs a Collaboration Agreement with a Le .. e for a Study Aimed at Further Development of a B
[ Tue, Oct 19th 2010 ] - Market Wire
Deciso da corte distrital recebida no processo da patente NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Micromet to Report Third Quarter 2010 Financial Results on November 9
[ Tue, Oct 19th 2010 ] - Market Wire
Tribunal de distrito emiti decisin en litigio por patentes de NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Gerichtsentscheidung im NPWT-Patentverfahren durch District Court
[ Tue, Oct 19th 2010 ] - Market Wire
Besluit arrondissementsrechtbank ontvangen in octrooizaak NPWT
[ Tue, Oct 19th 2010 ] - Market Wire
Forest Laboratories, Inc. Reports Second Quarter Fiscal Year 2011 Earnings Per Share of $1.00
[ Tue, Oct 19th 2010 ] - Market Wire
Aeterna Zentaris CEO to Chair Cancer Symposium Se .. Annual Congress of International Drug Discovery S
[ Tue, Oct 19th 2010 ] - Market Wire
Flamel Technologies Achieves Clinical Milestone w .. xtended Release Formulation of Interferon beta-1a
[ Tue, Oct 19th 2010 ] - Market Wire
Compugen Ltd. to Review Third Quarter 2010 Financial Results on Tuesday, October 26, 2010
Mon, October 18, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
ShangPharma Corporation Announces Pricing of Init .. Public Offering of its American Depositary Shares
[ Mon, Oct 18th 2010 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of AGA Medical Holdings, Inc. in Connection wi
[ Mon, Oct 18th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of AGA Medical Holdings, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
Finkelstein Thompson LLP Announces Investigation of China-Biotics, Inc.
[ Mon, Oct 18th 2010 ] - Market Wire
Cubist Announces Offering of Convertible Senior Notes
[ Mon, Oct 18th 2010 ] - Market Wire
Idera Pharmaceuticals to Present at the 17th Annual NewsMakers in the Biotech Industry Conference
[ Mon, Oct 18th 2010 ] - Market Wire
Emeritus Announces Lease Signing for 27 Senior Living Communities
[ Mon, Oct 18th 2010 ] - Market Wire
Columbia Laboratories to Present at the NewsMaker .. e Biotech Industry Conference on October 22, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
SuperGen to Announce 2010 Third Quarter Financial Results on October 25, 2010
[ Mon, Oct 18th 2010 ] - Market Wire
WellCare Announces Senior Management Team Appointments
[ Mon, Oct 18th 2010 ] - Market Wire
The Law Office of Abe Shainberg Launches an Inves .. eaches of Fiduciary Duty by the Board of AGA Medi
[ Mon, Oct 18th 2010 ] - Market Wire
Somaxon Pharmaceuticals Announces Paragraph IV ANDA Filing for Silenor
[ Mon, Oct 18th 2010 ] - Market Wire
Synta Pharmaceuticals to Present at the Newsmakers in Biotechnology Conference

Synta Pharmaceuticals to Present at the Newsmakers in Biotechnology Conference


Published on 2010-10-18 10:35:33 - Market Wire
  Print publication without navigation


LEXINGTON, Mass.--([ BUSINESS WIRE ])--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that President and CEO Safi Bahcall, Ph.D., will be presenting at the Newsmakers in Biotechnology Conference on Friday, October 22nd at 9:00 a.m. (ET) in New York.

A live audio webcast and replay of the presentation will be available on the "Investors" section of the Company's website, [ www.syntapharma.com ].

About Synta Pharmaceuticals

Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound library, an integrated discovery engine, and a diverse pipeline of clinical- and preclinical-stage drug candidates with distinct mechanisms of action and novel chemical structures. All Synta drug candidates were invented by Synta scientists using our compound library and discovery capabilities. For more information, please visit [ www.syntapharma.com ].

Contributing Sources